Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: celeryroot.com who wrote (10980)	11/11/1997 6:47:00 PM
From: tonyt	Respond to of 32384

SEATTLE--(BW HealthWire)--Nov. 11, 1997--Biotechnology, an "engine of growth" in the next century, will be in the spotlight for individual investors to assess first-hand at the 1997 Informed Investors Seattle Biotechnology Forum Saturday morning Dec. 13 in Seattle. "This is an industry that is just beginning," said technology and biotechnology authority Michael Murphy at the recent Informed Investors' Electronics & Technology Forum in San Diego. "We are about 20 years into a 40-year cycle in the semiconductor side and we're just starting a 40-year cycle in the biotech side. These two revolutions put together are going to change the whole economy and there are going to be huge, huge winners. We are already seeing the great new family fortunes being built -- the Bill Gates, Larry Ellison, Jim Clark, Mark Andreeson ... those are the kinds of stories you get when the economy is shifting. "To get the wind at your back as investors, you need to put your money into these new areas because this is where the growth is," Murphy said. "The most important thing to to take away today is that your future rate of return is going to be improved by allocating more of your assets to the new economy." Murphy said 90% of Wall Street analysts remain focused on "old economy" stocks such as autos, steels and the consumer growth stocks such as Coca Cola (NYSE:KO) and Phillip Morris (NYSE:MO). "Less than 10% are following the new economy of technology and biotechnology," he said. Murphy is Editor of the California Technology Stock Letter and runs the Murphy New World Technology Funds group which includes a biotech fund. He will be the keynote speaker to kick off the Forum. Murphy's former partner, Jim McCamant, Editor of the Medical Technology Stock Letter, is the featured luncheon speaker. Both will participate in a panel discussion, "What Biotechs To Buy Now," following lunch. The Forum runs from 8 a.m. - 12:30 p.m. followed by the luncheon program from 12:30 - 2 p.m. at the Sheraton Seattle, 1400 Sixth Ave. in downtown Seattle. The cost, including the luncheon, is $40 prepaid, $60 at the door. The cost for the luncheon program only is $30 prepaid, $50 at the door. Audio tapes of the Forum, which include all company presentations plus Murphy, McCamant and the panel discussion, are available for $45 plus $3.95 shipping/handling. Call 800/992-4683 to order, email info@informedinvestors.com or visit informedinvestors.com for information. In addition to talks from Murphy and McCamant, attendees will hear full financial presentations from Genentech (NYSE:GNE), Ligand Pharmaceuticals (NASDAQ:LGND) and Seattle area-based companies ALCIDE Corp. (NASDAQ:ALCD), ICOS Corp. (NASDAQ:ICOS), Cell Therapeutics (NASDAQ:CTIC), Sonus Pharmaceuticals (NASDAQ:SNUS) and QLT Phototherapeutics (NASDAQ:QLTIF) of Vancouver, B.C. Unlike invitation-only conferences sponsored by investment banking concerns, Informed Investors Forums are designed to give individual investors the same access to public company executives as analysts and mutual fund managers receive at private conferences. Attendees have ample opportunities to ask questions, too. Recent biotechnology forums organized by Informed Investors in July and August included the following companies: Chiron (NASDAQ:CHIR), Matrix Pharmaceutical (NASDAQ:MATX), Arris Pharmaceuticals (NASDAQ:ARRS), Connetics (NASDAQ:CNCT), Advanced Tissue Sciences (NASDAQ:ATIS), Isis Pharmaceuticals (NASDAQ:ISIP), La Jolla Pharmaceutical (NASDAQ:LJPC) and Maxim Pharmaceuticals (AMEX:MMP). Audio tapes are available of all presentations. Since 1993, Sacramento-based Informed Investors has been linking investors with management of public companies. Informed Investors represents individuals who collectively hold an estimated $1.3 billion in investable assets. CONTACT: Informed Investors Bob Taylor, Tim Quast or Steve Chanecka, 916/448-8222 or 800/992-4683 KEYWORD: WASHINGTON INDUSTRY KEYWORD: MEDICINE BIOTECHNOLOGY Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. URL: businesswire.com Copyright 1997, Business Wire